company background image
PRO logo

Societe de Promotion Pharmaceutique du Maghreb CBSE:PRO Stock Report

Last Price

د.م940.00

Market Cap

د.م940.0m

7D

-3.1%

1Y

n/a

Updated

27 Mar, 2024

Data

Company Financials

Societe de Promotion Pharmaceutique du Maghreb S.A.

CBSE:PRO Stock Report

Market Cap: د.م940.0m

Societe de Promotion Pharmaceutique du Maghreb S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Societe de Promotion Pharmaceutique du Maghreb
Historical stock prices
Current Share Priceد.م940.00
52 Week Highد.م1,110.00
52 Week Lowد.م933.00
Beta-0.15
1 Month Change-6.00%
3 Month Change-6.00%
1 Year Changen/a
3 Year Change11.24%
5 Year Change10.59%
Change since IPO-3.79%

Recent News & Updates

Recent updates

Shareholder Returns

PROMA PharmaceuticalsMA Market
7D-3.1%1.3%0.07%
1Yn/a11.4%20.8%

Return vs Industry: Insufficient data to determine how PRO performed against the MA Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how PRO performed against the MA Market.

Price Volatility

Is PRO's price volatile compared to industry and market?
PRO volatility
PRO Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement3.8%
10% most volatile stocks in MA Market6.6%
10% least volatile stocks in MA Market2.4%

Stable Share Price: PRO has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PRO's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1947n/aSalameh Al Araidehhttps://www.promopharm.co.ma

Societe de Promotion Pharmaceutique du Maghreb S.A. produces, commercializes, imports, and exports medicines, derma-pharmaceuticals, and cosmetic products in Africa. It subcontracts medicines for national and international laboratories. The company was founded in 1947 and is headquartered in Had-Soualem, Morocco.

Societe de Promotion Pharmaceutique du Maghreb S.A. Fundamentals Summary

How do Societe de Promotion Pharmaceutique du Maghreb's earnings and revenue compare to its market cap?
PRO fundamental statistics
Market capد.م940.00m
Earnings (TTM)د.م65.72m
Revenue (TTM)د.م747.84m

14.3x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PRO income statement (TTM)
Revenueد.م747.84m
Cost of Revenueد.م370.90m
Gross Profitد.م376.94m
Other Expensesد.م311.22m
Earningsد.م65.72m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)65.72
Gross Margin50.40%
Net Profit Margin8.79%
Debt/Equity Ratio23.1%

How did PRO perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

61%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.